Therapeutic goods regulation
The regulatory framework reflects and upholds the Australian community’s expectations around the safety and quality of therapeutic goods on the market.
-
Stryker is conducting an urgent recall of certain lots of the HeartSine Samaritan Public Access Defibrillator Pak (PAD-PAK). Stryker is now attempting to reach the small percentage of customers affected.
-
Dynamint X tablets pose a serious risk to your health and should not be taken.
-
Gold Max Blue capsules pose a serious risk to your health and should not be taken.
-
Summit Pharmacy Pty Ltd issued infringement notices for the alleged unlawful manufacturing of medicinal cannabis products
We have issued 4 infringement notices totalling $75,120 to Queensland based pharmacy Summit Pharmacy Pty Ltd, for the alleged unlawful manufacturing of medicinal cannabis products. -
Enforceable undertaking: Your Solution Compounding Pharmacy
We have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss. -
Your Solution Compounding Pharmacy undertakes to comply with advertising rules for weight-loss medicines
We have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
Communique from the meeting of the TGACC
-
This report provides information about our regulatory performance for the 2023-24 financial year.
-
Read our 2024 stakeholder survey report, which aims to improve the way we work with our stakeholders.